ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is Mediplantex National Pharmaceutical JSC ?
1
Poor Management Efficiency with a low ROE of 4.86%
- The company has been able to generate a Return on Equity (avg) of 4.86% signifying low profitability per unit of shareholders funds
2
The company is Net-Debt Free
3
Positive results in Mar 26
- ROCE(HY) Highest at 5.67%
- OPERATING PROFIT(Q) Highest at VND 10,057.11 MM
- DEBTORS TURNOVER RATIO(HY) Highest at 6.32 times
4
With ROE of 4.62%, it has a fair valuation with a 0.77 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -23.33%, its profits have risen by 0.9% ; the PEG ratio of the company is 16.6
- At the current price, the company has a high dividend yield of 5.9
5
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -23.33% returns in the last 1 year, the stock has also underperformed Vietnam VN Ho Chi Minh Index in each of the last 3 annual periods
Real-Time Research ReportHow much should you hold?
- Overall Portfolio exposure to Mediplantex National Pharmaceutical JSC should be less than 10%
- Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock
Is Mediplantex National Pharmaceutical JSC for you?
Medium Risk, Low Return
Absolute
Risk Adjusted
Volatility
Mediplantex National Pharmaceutical JSC
-23.33%
-0.75
37.28%
Vietnam VN Ho Chi Minh Index
38.87%
1.81
21.48%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-6.78%
EBIT Growth (5y)
-5.24%
EBIT to Interest (avg)
3.00
Debt to EBITDA (avg)
Net Debt is too low
Net Debt to Equity (avg)
0.02
Sales to Capital Employed (avg)
1.09
Tax Ratio
21.62%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.88%
ROE (avg)
4.86%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.77
EV to EBIT
12.12
EV to EBITDA
9.58
EV to Capital Employed
0.77
EV to Sales
0.70
PEG Ratio
16.58
Dividend Yield
5.88%
ROCE (Latest)
6.33%
ROE (Latest)
4.62%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
No Trend
Bearish
OBV
No Trend
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend17What is working for the Company
ROCE(HY)
Highest at 5.67%
OPERATING PROFIT(Q)
Highest at VND 10,057.11 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 6.32 times
OPERATING PROFIT MARGIN(Q)
Highest at 11.34 %
PRE-TAX PROFIT(Q)
At VND 7,439.44 MM has Grown at 49.16%
NET PROFIT(Q)
At VND 5,926.34 MM has Grown at 55.22%
-9What is not working for the Company
INTEREST(HY)
At VND 2,393.32 MM has Grown at 167.93%
RAW MATERIAL COST(Y)
Grown by 7.96% (YoY
CASH AND EQV(HY)
Lowest at VND 73,525.87 MM
Here's what is working for Mediplantex National Pharmaceutical JSC
Operating Profit
Highest at VND 10,057.11 MM and Grown
In each period in the last five periodsMOJO Watch
Near term Operating Profit trend is quite positive
Operating Profit (VND MM)
Operating Profit Margin
Highest at 11.34 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Pre-Tax Profit
At VND 7,439.44 MM has Grown at 49.16%
over average net sales of the previous four periods of VND 4,987.45 MMMOJO Watch
Near term Pre-Tax Profit trend is positive
Pre-Tax Profit (VND MM)
Net Profit
At VND 5,926.34 MM has Grown at 55.22%
over average net sales of the previous four periods of VND 3,817.93 MMMOJO Watch
Near term Net Profit trend is positive
Net Profit (VND MM)
Debtors Turnover Ratio
Highest at 6.32 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Depreciation
At VND 1,660.37 MM has Grown at inf%
period on period (QoQ)MOJO Watch
The expenditure on assets done by the company has gone into productive use which should positively reflect in the future sales
Depreciation (VND MM)
Here's what is not working for Mediplantex National Pharmaceutical JSC
Interest
At VND 2,393.32 MM has Grown at 167.93%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (VND MM)
Cash and Eqv
Lowest at VND 73,525.87 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
Raw Material Cost
Grown by 7.96% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin
Raw Material Cost as a percentage of Sales
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
